NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:
Lululemon Athletica Inc., down $6.78 to $348.43.
The athletic apparel maker warned investors that a surge in virus cases hurt its fourth-quarter financial results.
Cardinal Health Inc., down $3.21 to $51.03.
The medical products maker and distributor said supply chain problems will hurt profits for its medical segment in fiscal 2022.
Take-Two Interactive Software Inc., down $21.61 to $142.99.
The maker of “Grand Theft Auto” is buying Zynga, maker of “FarmVille,” in a cash-and-stock deal valued at about $12.7 billion.
Jazz Pharmaceuticals Plc., up $12.06 to $146.49.
The biopharmaceutical company gave investors an encouraging development and financial forecast.
BioMarin Pharmaceutical Inc., up 14 cents to $84.39.
The drug developer reported encouraging results from a study on a potential hemophilia treatment.
Tilly's Inc., down $1.34 to $14.28.
The clothing and accessories retailer trimmed its financial forecast for the fourth quarter.
Owens & Minor Inc. (OMI), up 27 cents to $45.35.
The health care logistics company is buying Apria for about $1.45 billion.
Halozyme Therapeutics Inc., down $1.30 to $35.99.
Investors were disappointed by the biopharmaceutical company's financial forecast for fiscal 2022.
Before you consider Take-Two Interactive Software, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Take-Two Interactive Software wasn't on the list.
While Take-Two Interactive Software currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
